|
GB8918616D0
(en)
|
1989-08-15 |
1989-09-27 |
Univ Glasgow |
Herpes simplex virus type 1 mutant
|
|
US5849572A
(en)
|
1990-10-10 |
1998-12-15 |
Regents Of The University Of Michigan |
HSV-1 vector containing a lat promoter
|
|
US5804413A
(en)
|
1992-07-31 |
1998-09-08 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Herpes simplex virus strains for gene transfer
|
|
AU687117B2
(en)
|
1993-10-25 |
1998-02-19 |
Canji, Inc. |
Recombinant adenoviral vector and methods of use
|
|
GB9415319D0
(en)
|
1994-07-29 |
1994-09-21 |
Medical Res Council |
HSV viral vector
|
|
US5846782A
(en)
|
1995-11-28 |
1998-12-08 |
Genvec, Inc. |
Targeting adenovirus with use of constrained peptide motifs
|
|
US5801030A
(en)
|
1995-09-01 |
1998-09-01 |
Genvec, Inc. |
Methods and vectors for site-specific recombination
|
|
US5837511A
(en)
|
1995-10-02 |
1998-11-17 |
Cornell Research Foundation, Inc. |
Non-group C adenoviral vectors
|
|
US5849561A
(en)
|
1997-05-22 |
1998-12-15 |
Cornell Research Foundation, Inc. |
Method for the production of non-group C adenoviral vectors
|
|
AU8605598A
(en)
|
1997-07-31 |
1999-02-22 |
University Of Pittsburgh |
Targeted hsv vectors
|
|
US6436392B1
(en)
|
1998-05-20 |
2002-08-20 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors
|
|
US6759237B1
(en)
|
1998-11-05 |
2004-07-06 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
|
|
US6562943B1
(en)
*
|
1999-04-21 |
2003-05-13 |
Zycos, Inc. |
Peptide epitopes recognized by disease promoting CD4+ T lymphocytes
|
|
ATE318923T1
(de)
|
2000-06-01 |
2006-03-15 |
Univ North Carolina |
Doppelsträngige parvovirus-vektoren
|
|
US7122181B2
(en)
|
2000-12-19 |
2006-10-17 |
Research Development Foundation |
Lentiviral vector-mediated gene transfer and uses thereof
|
|
JP4608210B2
(ja)
|
2001-05-31 |
2011-01-12 |
ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド |
キメラアルファウイルスレプリコン粒子
|
|
US20070129307A1
(en)
|
2001-06-22 |
2007-06-07 |
The University Of British Columbia |
Insulin epitopes for the treatment of type 1 diabetes
|
|
ATE527347T1
(de)
|
2001-08-02 |
2011-10-15 |
Inst Clayton De La Rech |
Verfahren und zusammensetzungen im zusammenhang mit verbesserten lentivirusvektor- produktionssystemen
|
|
ES2330202T5
(es)
|
2001-09-06 |
2014-01-20 |
Alphavax, Inc. |
Sistemas vectores basados en replicones de alfavirus
|
|
RU2305708C2
(ru)
|
2001-10-02 |
2007-09-10 |
Энститю Клейтон Де Ля Решерш |
Рекомбинантный лентивирусный вектор, клетка-хозяин, трансдуцированная лентивирусным вектором, способ ее трансдукции и применение
|
|
PT1453547T
(pt)
|
2001-12-17 |
2016-12-28 |
Univ Pennsylvania |
Sequências do vírus adeno-associado (aav) do serotipo 8, vetores contendo as mesmas, e utilizações destas
|
|
DE60333487D1
(de)
|
2002-12-13 |
2010-09-02 |
Genetix Pharmaceuticals Inc |
Therapeutische retrovirus-vektoren für gentherapie
|
|
US7510872B2
(en)
|
2003-02-26 |
2009-03-31 |
Nationwide Children's Hospital |
Recombinant adeno-associated virus production
|
|
US7186699B2
(en)
|
2003-06-03 |
2007-03-06 |
Cell Genesys, Inc. |
Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes
|
|
EP1486567A1
(en)
|
2003-06-11 |
2004-12-15 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Improved adeno-associated virus (AAV) vector for gene therapy
|
|
WO2005038035A2
(en)
|
2003-10-15 |
2005-04-28 |
University Of Iowa Research Foundation |
Methods for producing and using in vivo pseudotyped retroviruses
|
|
MX2007010008A
(es)
|
2005-02-16 |
2008-01-18 |
Lentigen Corp |
Vectores lentivirales y su uso.
|
|
JP2008541730A
(ja)
|
2005-05-23 |
2008-11-27 |
ヴァクシン インコーポレイテッド |
高力価かつ複製コンピテントアデノウイルス不含である組換えアデノウイルスベクターの迅速な作成法
|
|
FI20050814A0
(fi)
|
2005-08-11 |
2005-08-11 |
Procollagen Oy |
Menetelmä nivelreumassa muodostuvien kollageeniautovasta-aineiden havaitsemiseksi
|
|
DE602006019916D1
(de)
|
2005-12-12 |
2011-03-10 |
Canji Inc |
Adenovirale expressionsvektoren mit einer expressionskassette im e1-bereich und einer inaktivierten e2b-polymerase
|
|
GB0526211D0
(en)
|
2005-12-22 |
2006-02-01 |
Oxford Biomedica Ltd |
Viral vectors
|
|
WO2007123976A2
(en)
|
2006-04-18 |
2007-11-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Antibody profiling for determination of patient responsiveness
|
|
ES2465996T3
(es)
|
2006-05-25 |
2014-06-09 |
Sangamo Biosciences, Inc. |
Métodos y composiciones para la inactivación genética
|
|
ES2586210T3
(es)
|
2006-12-14 |
2016-10-13 |
Sangamo Biosciences, Inc. |
Proteínas de dedo de zinc no canónicas optimizadas
|
|
US20100047256A1
(en)
|
2007-01-25 |
2010-02-25 |
Imperial Innovations Limited |
Methods
|
|
DK2185192T3
(en)
|
2007-08-03 |
2019-02-18 |
Pasteur Institut |
LENTIVIRAL TRANSFER VECTORS AND THEIR MEDICAL USES
|
|
EP2215223B1
(en)
|
2007-10-31 |
2013-05-01 |
Precision Biosciences, Inc. |
Rationally-designed single-chain meganucleases with non-palindromic recognition sequences
|
|
JP2011503232A
(ja)
|
2007-11-20 |
2011-01-27 |
ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド |
免疫応答の調節
|
|
JP2011505809A
(ja)
|
2007-12-07 |
2011-03-03 |
プレシジョン バイオサイエンシズ，インク． |
ヒトゲノムのＤＮａｓｅ高感受性領域に見出される認識配列を有する合理的に設計されたメガヌクレアーゼ
|
|
WO2009114321A2
(en)
|
2008-03-11 |
2009-09-17 |
Precision Biosciencs, Inc. |
Rationally-designed meganucleases for maize genome engineering
|
|
WO2009117597A1
(en)
|
2008-03-21 |
2009-09-24 |
The Brigham And Women's Hospital, Inc. |
Modulation of the immune response
|
|
WO2009146179A1
(en)
|
2008-04-15 |
2009-12-03 |
University Of Iowa Research Foundation |
Zinc finger nuclease for the cftr gene and methods of use thereof
|
|
WO2010033722A2
(en)
|
2008-09-17 |
2010-03-25 |
Isogenis, Inc. |
Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof
|
|
JP2012512175A
(ja)
*
|
2008-12-15 |
2012-05-31 |
バインド バイオサイエンシズ インコーポレイテッド |
治療薬を徐放するための長時間循環性ナノ粒子
|
|
WO2010114948A2
(en)
|
2009-04-02 |
2010-10-07 |
University Of Florida Research Foundation, Inc. |
An inducible system for highly efficient production of recombinant adeno-associated virus (raav) vectors
|
|
EP2480659A2
(en)
|
2009-09-24 |
2012-08-01 |
Cellectis |
Meganuclease reagents of uses thereof for treating genetic diseases caused by frame shift/non sense mutations
|
|
WO2011043719A1
(en)
|
2009-10-05 |
2011-04-14 |
Ya-Fang Mei |
Replicating viral vectors for gene therapy
|
|
US8956828B2
(en)
|
2009-11-10 |
2015-02-17 |
Sangamo Biosciences, Inc. |
Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
|
|
WO2011072246A2
(en)
|
2009-12-10 |
2011-06-16 |
Regents Of The University Of Minnesota |
Tal effector-mediated dna modification
|
|
EP2660318A1
(en)
|
2010-02-09 |
2013-11-06 |
Sangamo BioSciences, Inc. |
Targeted genomic modification with partially single-stranded donor molecules
|
|
US8927514B2
(en)
|
2010-04-30 |
2015-01-06 |
City Of Hope |
Recombinant adeno-associated vectors for targeted treatment
|
|
EP2675484B1
(en)
|
2011-02-14 |
2018-05-30 |
The Children's Hospital of Philadelphia |
Improved aav8 vector with enhanced functional activity and methods of use thereof
|
|
US20140155469A1
(en)
|
2011-04-19 |
2014-06-05 |
The Research Foundation Of State University Of New York |
Adeno-associated-virus rep sequences, vectors and viruses
|
|
MX374963B
(es)
|
2011-04-29 |
2025-03-06 |
Selecta Biosciences Inc |
Nanoportadores sintéticos tolerogénicos para reducir las respuestas de anticuerpos.
|
|
KR101873447B1
(ko)
|
2011-06-22 |
2018-07-03 |
삼성디스플레이 주식회사 |
신규한 화합물 및 이를 포함한 유기발광 소자
|
|
US20150166969A1
(en)
|
2012-02-24 |
2015-06-18 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for the treatment of hemoglobinopathies
|
|
EP2638896A1
(en)
*
|
2012-03-14 |
2013-09-18 |
Bioneer A/S |
Cationic liposomal drug delivery system for specific targeting of human cd14+ monocytes in whole blood
|
|
AU2013240248B2
(en)
|
2012-03-26 |
2018-12-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Delivery of packaged RNA to mammalian cells
|
|
NZ701693A
(en)
|
2012-04-18 |
2017-02-24 |
The Children’S Hospital Of Philadelphia |
Composition and methods for highly efficient gene transfer using aav capsid variants
|
|
US9738879B2
(en)
|
2012-04-27 |
2017-08-22 |
Duke University |
Genetic correction of mutated genes
|
|
JP2015529466A
(ja)
|
2012-09-14 |
2015-10-08 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
鎌状赤血球症の幹細胞遺伝子治療のためのレンチウイルスベクター
|
|
US9181535B2
(en)
|
2012-09-24 |
2015-11-10 |
The Chinese University Of Hong Kong |
Transcription activator-like effector nucleases (TALENs)
|
|
US9624510B2
(en)
|
2013-03-01 |
2017-04-18 |
The Wistar Institute |
Adenoviral vectors comprising partial deletions of E3
|
|
EP2968435B1
(en)
|
2013-03-12 |
2019-01-30 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Synthetic peptides for the treatment of autoimmune diseases
|
|
EP2983791A4
(en)
|
2013-04-11 |
2016-11-09 |
Brigham & Womens Hospital |
METHOD AND COMPOSITIONS FOR TREATING AUTOIMMUNE DISEASES
|
|
US9873907B2
(en)
|
2013-05-29 |
2018-01-23 |
Agilent Technologies, Inc. |
Method for fragmenting genomic DNA using CAS9
|
|
US9526784B2
(en)
|
2013-09-06 |
2016-12-27 |
President And Fellows Of Harvard College |
Delivery system for functional nucleases
|
|
US9322037B2
(en)
|
2013-09-06 |
2016-04-26 |
President And Fellows Of Harvard College |
Cas9-FokI fusion proteins and uses thereof
|
|
US20150165054A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting caspase-9 point mutations
|
|
CA2933554A1
(en)
|
2013-12-12 |
2015-06-18 |
The Brigham And Women's Hospital, Inc. |
Treating neurodegenerative disease
|
|
US20160060358A1
(en)
*
|
2014-08-28 |
2016-03-03 |
California Institute Of Technology |
Induction of antigen-specific tolerance
|
|
US20170348415A1
(en)
*
|
2014-09-03 |
2017-12-07 |
Moderna Therapeutics, Inc. |
Tolerogenic compositions and methods
|
|
JP2017537083A
(ja)
|
2014-11-12 |
2017-12-14 |
ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドＴｈｅ Ｂｒｉｇｈａｍ ａｎｄ Ｗｏｍｅｎ’ｓ Ｈｏｓｐｉｔａｌ， Ｉｎｃ． |
自己免疫疾患におけるメラトニン
|
|
US20180071376A1
(en)
*
|
2015-03-23 |
2018-03-15 |
The Brigham And Women`S Hospital, Inc. |
Tolerogenic nanoparticles for treating diabetes mellitus
|
|
GB201506112D0
(en)
|
2015-04-10 |
2015-05-27 |
Midatech Ltd And Inst Nationale De La Sant� Et De Al Rech Medicale And University College Car |
Nanoparticle-based antigen specific immunotherapy
|
|
WO2016168670A2
(en)
|
2015-04-16 |
2016-10-20 |
Longevica Therapeutics Inc. |
Methods for extending lifespan and methods of screening known pharmacological agents for new uses
|
|
EP3095440B1
(en)
*
|
2015-05-19 |
2020-01-15 |
PLS-Design GmbH |
Antigen-specific immunotherapy using tolerizing liposomes
|
|
US20170121683A1
(en)
|
2015-11-03 |
2017-05-04 |
Regents Of The University Of Minnesota |
Aryl hydrocarbon receptor disruption and enhancement
|
|
EP3713937A2
(en)
|
2017-11-20 |
2020-09-30 |
Ariagen, Inc. |
Indole compounds as aryl hydrocarbon receptor (ahr) modulators
|
|
CN112384204B
(zh)
|
2018-02-26 |
2023-03-14 |
安托瑞斯公司 |
致耐受性脂质体及其使用方法
|
|
US20230054194A1
(en)
|
2018-11-19 |
2023-02-23 |
Ariagen, Inc. |
Methods of Treating Cancer
|